Free Trial

Jin Medical International (NASDAQ:ZJYL) Cut to "Sell (D+)" at Weiss Ratings

Jin Medical International logo with Medical background

Key Points

  • Jin Medical International (NASDAQ:ZJYL) was downgraded from a "hold (C-)" to a "sell (D+)" rating by Weiss Ratings.
  • The stock experienced a slight decline of 0.7%, trading at $0.34 during midday trading, with a 12-month low of $0.30.
  • Founded in 2006, Jin Medical International specializes in the design and manufacturing of wheelchairs and other mobility aids, including oxygen concentrators.
  • MarketBeat previews top five stocks to own in November.

Jin Medical International (NASDAQ:ZJYL - Get Free Report) was downgraded by Weiss Ratings from a "hold (c-)" rating to a "sell (d+)" rating in a research report issued on Friday,Weiss Ratings reports.

Jin Medical International Stock Down 0.7%

Shares of ZJYL stock traded down $0.00 during mid-day trading on Friday, hitting $0.34. 155,272 shares of the stock traded hands, compared to its average volume of 262,193. Jin Medical International has a twelve month low of $0.30 and a twelve month high of $2.36. The company's 50-day simple moving average is $0.57 and its 200-day simple moving average is $0.67.

Jin Medical International Company Profile

(Get Free Report)

Jin Medical International Ltd. engages in the design, development, manufacturing, and sale of wheelchair and other living aids products for people with disabilities or impaired mobility in China and internationally. It also offers oxygen concentrators and bathing machines. The company was founded in 2006 and is based in Changzhou, China.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Jin Medical International Right Now?

Before you consider Jin Medical International, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Jin Medical International wasn't on the list.

While Jin Medical International currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report
Like this article? Share it with a colleague.